Task: Answer the multiple-choice question.
Question: Which drug exhibits a 2.262% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) COc1ccc(C(C(=O)NCC2CCCO2)N(Cc2cccs2)C(=O)c2snc(C(N)=O)c2N)cc1OC
b) CC1CCc2[nH]c3ccc(C(=O)NCCCOC(C)C)cc3c2C1
Answer: b. CC1CCc2[nH]c3ccc(C(=O)NCCCOC(C)C)cc3c2C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCc2[nH]c3ccc(C(=O)NCCCOC(C)C)cc3c2C1
CC1CCc2[nH]c3ccc(C(=O)NCCCOC(C)C)cc3c2C1
6-methyl-N-(3-propan-2-yloxypropyl)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide